Text Size

In vitro and in vivo evaluation of a preservative-free cationic emulsion of latanoprost in corneal wound healing models

Liang H., Baudouin C., Daull P., Garrigue J.-S., Buggage R., Brignole-Baudouin F.


  • 2012
  • Cornea
View publication
  • Therapeutic Area

    Glaucoma

  • Technology

    Pharmacology

  • Categories

    Preclinical development

  • Affiliations

    INSERM, U968, Department of Therapy, Paris, France; UPMC University Paris 06, UMR-S 968, Institut de la Vision, Paris F-75012, France; CNRS, UMR-7210, Paris, France; Department of Service, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DHOS CIC 503, Paris, France; Assistance Publique - Hôpitaux de Paris Hôpital Ambroise Paré, Service d'Ophtalmologie, Boulogne-Billancourt, France; Université Versailles Saint-Quentin-en-Yvelines, Versailles, France; Novagali Pharma, Evry, France; Laboratoire de Toxicologie, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris Descartes, Paris, France

Related Publications

The Antiglaucoma Agent and EP2 Receptor Agonist Omidenepag Does Not Affect Eyelash Growth in Mice

Esaki Y., Katsuta O., Kamio H., Noto T., Mano H., Iwamura R., Yoneda K., Odani-Kawabata N., Morishima K., Shams N.K.


A comparative study of a preservative-free latanoprost cationic emulsion (catioprost) and a BAK-preserved latanoprost solution in animal models

Daull P., Buggage R., Lambert G., Faure M.-O., Serle J., Wang R.-F., Garrigue J.-S.


The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo

Pellinen P., Huhtala A., Tolonen A., Lokkila J., Mäenpää J., Uusitalo H.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022